TY  - GEN
AU  - Engesæter,Birgit
AU  - Engebraaten,Olav
AU  - Flørenes,Vivi Ann
AU  - Mælandsmo,Gunhild Mari
TI  - Dacarbazine and the agonistic TRAIL receptor-2 antibody lexatumumab induce synergistic anticancer effects in melanoma
SN  - 1932-6203
PY  - 2013///0306
KW  - Animals
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Agents
KW  - Apoptosis
KW  - drug effects
KW  - Caspases
KW  - metabolism
KW  - Cell Death
KW  - Cell Line, Tumor
KW  - Cell Survival
KW  - Dacarbazine
KW  - Drug Synergism
KW  - Female
KW  - Humans
KW  - Inhibitor of Apoptosis Proteins
KW  - Melanoma
KW  - Mice
KW  - Proto-Oncogene Proteins c-bcl-2
KW  - Receptors, TNF-Related Apoptosis-Inducing Ligand
KW  - agonists
KW  - Tumor Stem Cell Assay
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1371/journal.pone.0045492
ER  -